HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Concerns Survey Shows More Than Half US Parents Provide Supplements For Children

Executive Summary

Nationwide survey on parent's concerns about children’s health care found 52% of children regularly use supplements, and almost 80% of parents want supplements regulated by FDA.

You may also be interested in...



US Supplement Industry To Enjoy Recognition Week Under Resolution Lee, Sinema Propose In Senate

Senate recognizes “dietary supplements have become a routine part of the lives of millions of individuals in the United States” and “the contributions of the natural product industry to the workforce and economy,” says ‘‘Natural Product Industry Week’’ resolution proposed by Sens. Mike Lee and Kyrsten Sinema.

USPSTF Doesn’t See Forest Of VMS Benefits For Trees Of Reducing Cancer, Heart Disease Risks

US Preventative Services Task Force concludes evidence doesn't support  recommending VMS use to prevent cancer or cardiovascular disease. Trade groups and a natural medicine expert say task force's focus is narrow and its recommendation misleading. 

CDC Data On Children's Melatonin Emergencies Reported Without Context, Clarity, CRN Contends

CRN argues reporting melatonin overdoses are up 530% in past 10 years isn’t accurate representation of poison control report analysis by CDC.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel